Pronounced State-Level Disparities in Prescription of Cannabinoids to Medicaid Patients
Abstract Introduction: Dronabinol is approved in the USA for chemotherapy-induced nausea as well as vomiting and HIV-induced anorexia, while cannabidiol…
Abstract Introduction: Dronabinol is approved in the USA for chemotherapy-induced nausea as well as vomiting and HIV-induced anorexia, while cannabidiol…
Abstract Workaholism, a term borrowed from the language around alcoholism, first appeared in academic writing in the late 1960s. This…
Abstract Background: Cannabis marketing exposure via social media may impact use in youth and young adults. Most states with recreational…
Abstract Background: Poor outcomes of COVID-19 have been reported in older males with medical comorbidities including substance use disorder. However,…
Abstract The Indigenous Sámi have poorer mental health than the majority population and fairly equal access to professional mental healthcare.…
Abstract Cannabidiol (CBD), a major non-psychoactive phytocannabinoid in cannabis, is an effective treatment for some forms of epilepsy and pain.…
Abstract The potential therapeutic benefits of cannabidiol (CBD) require further study. Here, we report a triple-blind (participant, investigator, and outcome…
Abstract The use of terpenoid compounds in different neural-related conditions is becoming useful for several illnesses. Another possible activity of…
Abstract The aim of the study was to analyze the influence of mullein flower extract addition on the oxidative stability…
Abstract Introduction: Cannabidiol (CBD) is a non-intoxicating phytocannabinoid with increasing popularity due to its purported therapeutic efficacy for numerous off-label…